107 related articles for article (PubMed ID: 3946247)
1. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
Samuel P; Chin B; Fenderson RW; Schoenfeld BH; Gonasun LM; Lieberman S
Am J Cardiol; 1986 Feb; 57(5):24C-28C. PubMed ID: 3946247
[TBL] [Abstract][Full Text] [Related]
2. Effect of pindolol on changes in serum lipids induced by hydrochlorthiazide.
Frithz G
Eur J Clin Pharmacol; 1989; 37(3):221-3. PubMed ID: 2612534
[TBL] [Abstract][Full Text] [Related]
3. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Lehtonen A
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
Neusy AJ; Valeri A
J Hum Hypertens; 1990 Aug; 4(4):453-7. PubMed ID: 2258893
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta blockers on blood lipid profile.
Lehtonen A
Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
[TBL] [Abstract][Full Text] [Related]
6. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females.
Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S
J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913
[TBL] [Abstract][Full Text] [Related]
7. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
[TBL] [Abstract][Full Text] [Related]
8. Effect of pindolol on serum lipids and lipid metabolizing enzymes.
Lehtonen A; Hietanen E; Marniemi J; Peltonen P; Niskanen J
Br J Clin Pharmacol; 1982; 13(Suppl 2):445S-447S. PubMed ID: 7104159
[TBL] [Abstract][Full Text] [Related]
9. Effects of doxazosin and hydrochlorothiazide on lipid levels in Korean patients with essential hypertension.
Jones DW; Sands CD
J Cardiovasc Pharmacol; 1993 Sep; 22(3):431-7. PubMed ID: 7504134
[TBL] [Abstract][Full Text] [Related]
10. Effect of alpha- and beta-blocker therapy on blood lipids: European experience.
Leren P
Am J Med; 1984 Feb; 76(2A):67-71. PubMed ID: 6142644
[TBL] [Abstract][Full Text] [Related]
11. The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
Johnson BF; Weiner B; Marwaha R; Johnson J
J Clin Pharmacol; 1986 Apr; 26(4):258-63. PubMed ID: 3517076
[TBL] [Abstract][Full Text] [Related]
12. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients.
Lehtonen A
Cardiovasc Drugs Ther; 1988 Jan; 1(5):549-51. PubMed ID: 3154682
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
15. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
Sasaki N; Saito Y; Shinomiya M; Kanzaki T; Ishikawa Y; Mori S; Kobayashi J; Murano S; Nishide T; Morisaki N
Clin Ther; 1990; 12(2):157-64. PubMed ID: 2354485
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemic effects of cigarette smoking on beta-blocker-induced serum lipid changes in systemic hypertension.
Vyssoulis GP; Karpanou EA; Pitsavos CE; Toutouza MA; Paleologos AA; Toutouzas PK
Am J Cardiol; 1991 May; 67(11):987-92. PubMed ID: 1673284
[TBL] [Abstract][Full Text] [Related]
17. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
[TBL] [Abstract][Full Text] [Related]
18. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
[TBL] [Abstract][Full Text] [Related]
19. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial.
Middeke M; Weisweiler P; Schwandt P; Holzgreve H
Clin Cardiol; 1987 Feb; 10(2):94-8. PubMed ID: 3545579
[TBL] [Abstract][Full Text] [Related]
20. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
